Hazard classification of chemicals inducing haemolytic anaemia: An EU regulatory perspective

Regulatory Toxicology and Pharmacology

Volumn 45, Issue 3, 2006, Pages 229-241

  Muller, Andre ^a   Jacobsen, Helene ^b   Healy, Edel ^c   McMickan, Sinead ^c   Istace, Fréderique ^d   Blaude, Marie Noëlle ^d   Howden, Peter ^e   Fleig, Helmut ^f   Schulte, Agnes ^g  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c Health and Safety Authority   (Ireland)

^d SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^e Industrial Chemicals Unit   (United Kingdom)

^f BASF AG   (Germany)

^g FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

Author keywords

Classification; Council Directive 67 548 EEC; Erythrocytes; Haematopoietic system; Haemolytic anaemia; Haemosiderin; Methaemoglobin; Regulatory toxicology; Repeated dose

Indexed keywords

BILIRUBIN; ERYTHROPOIETIN; HEMOGLOBIN; HEMOSIDERIN; IRON; LACTATE DEHYDROGENASE;

ANEMIA; ARTICLE; BLOOD CHEMISTRY; BONE MARROW; CORRELATION ANALYSIS; DECISION MAKING; ERYTHROCYTE COUNT; ERYTHROCYTE DISORDER; ERYTHROCYTE LIFESPAN; ERYTHROCYTE VOLUME; EUROPEAN UNION; GALLSTONE FORMATION; HEMATOCRIT; HEMATOPOIESIS; HEMOGLOBINURIA; HEMOLYTIC ANEMIA; HEMOSIDEROSIS; HUMAN; INTRAVASCULAR HEMOLYSIS; KIDNEY; LIVER; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; METHEMOGLOBINEMIA; NONHUMAN; PRIORITY JOURNAL; RETICULOCYTE; RISK ASSESSMENT; SPLEEN; TOXICITY TESTING; URINALYSIS;

ANEMIA, HEMOLYTIC; EUROPEAN UNION; HAZARDOUS SUBSTANCES; HUMANS; OCCUPATIONAL EXPOSURE;

RODENTIA;

EID: 33746255256     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2006.04.004     Document Type: Article

References (53)

1. Arrezzini B., Lunghi B., Lungarella G., and Gardi C. Iron overload enhances the development of experimental liver cirrhosis in mice. Int. J. Biochem. Cell Biol. 35 (2003) 486-495
2. Aydogdu I., Sari R., Ulu R., and Sevinc A. The frequency of gallbladder stones in patients with pernicious anaemia. J. Surg. Res. 10 2 (2001) 120-123
3. Azemoto R., Tsuchiya Y., Ai T., Murayama H., Nakagawa Y., Saisho H., and Ohto M. Does gallstone formation after open cardiac surgery result only from latent haemolysis by replaced valves?. Am. J. Gastroenterol. 9 10 (1996) 2185-2189
4. Bader-Meunier B., Gauthier F., Archambaud F., Cynober T., Mielot F., Dommergues J.-P., Warszawski J., Mohandas N., and Tchernia G. Long-term evaluation of the beneficial effect of subtotal splenectomy for management of hereditary spherocytosis. Blood 9 2 (2001) 399-403
5. Bailly Y., and Duprat P. Normal blood cell values, rat. In: Jones T.C., Ward J.M., Mohr U., and Hunt R.D. (Eds). Hemopoietic System (1990), Springer-Verlag, Berlin 27-38
6. Baker S.J., and DeMaeyer E.M. Nutritional anemia: its understanding and control with special reference to the work of the World Health Organization. Am. J. Clin. Nutr. 3 2 (1979) 368-417
7. Barr F., Brabin L., Agbaje S., Buseri F., Ikimalo J., and Briggs N. Reducing iron deficiency anaemia due to heavy menstrual blood loss in Nigerian rural adolescent. Public Health Nutr. 1 4 (1998) 249-257
8. Beilby J.P., Prins A.W., and Swanson N.T. Determination of hepatic iron concentration in fresh and paraffin-embedded tissue. Clin. Chem. 45 (1999) 573-574
9. Beutler E. Methaemoglobinemia and other causes of cyanosis. In: Beutler E., Lichtman M.A., Coller B.S., and Kipps T.J. (Eds). Williams Hematology. fifth ed. (1995), McGraw-Hill, Inc., New York 654-662
10. Blom, M. in RIVM Rapport 601516007 Luttik R; Raaij MTM van (eds) 2001 Factsheets for the (eco)Toxicological Risk Assessment Strategy of the National Institute of Public Health and the Environment (RIVM).
11. Bonatsos G., Birbas K., Toutouzas K., and Durakis N. Laparoscopic cholecystectomy in adults with sickle cell disease. Surg. Endosc. 1 8 (2001) 816-819
12. Ciccoli L., Ferrali M., Rossi V., Signorini C., Alessandrini C., and Comporti M. Hemolytic drugs aniline and daponse induce iron release in erythrocytes and increase the free iron pool in spleen and liver. Toxicol. Lett. 110 (1999) 57-66
13. Danse L.H.J.C., and Crichton D.N. Pigment deposition, rat, mouse. In: Jones T.C., Ward J.M., Mohr U., and Hunt R.D. (Eds). Monographs on Pathology of Laboratory Animals Sponsored by the International Life Sciences Institute. Hemopoietic System (1990), Springer-Verlag, Berlin 226-232
14. Diagne I., Badiane M., Moreira C., Signate-Sy H., Ndiaye O., Lopez-Sall P., Preira-Sylla G., Camara B., Diouf S., Diack-Mbaye A., and Fall M. Lithiase biliaire et drepanocytose homozygote en pediatrie a Dakar (Senegal).[Cholelithiasis and homozygote drepanocytosis in children in Dakar (Senegal)]. Arch. Pediatr. 6 12 (1999) 1286-1292
15. Duellmann J., Wulfhekel U., Nielsen P., and Heinrich H.C. Iron overload of the liver by trimethylhexanoylferrocene in rats. Acta Anat. 143 (1992) 96-108
16. Emerit J., Beaumont C., and Trivin F. Iron metabolism, free radicals, and oxidative injury. Biomed. Pharmacother. 55 (2001) 333-339
17. Erslev H.M., and Beutler V. Structure and function of haemoglobin. In: Beutler E., Lichtman M.A., Coller B.S., and Kipps T.J. (Eds). Hematology. fifth ed. (1995), McGraw-Hill, Inc., New York P417-P438
18. EU, 1967. Council Directive 67/548/EEC of 27 June 1967 on the Approximation of Laws, Regulations and Administrative Provisions Relating to the Classification, Packaging and Labelling of Dangerous Substances. O.J. No. P196,16. 8. 1967, p. 1.
19. Fairbanks V.F., and Baldus W.P. Iron overload. In: Beutler E., Lichtman M.A., Coller B.S., and Kipps T.J. (Eds). Hematology. fifth ed. (1995), McGraw-Hill, Inc., New York P529-P535
20. Giger U., and Noble N.A. Determination of erythrocyte pyruvate kinase deficiency in Basenjis with chronic hemolytic anemia. JAVMA 198 (1991) 1755-1761
21. Goswami R.P., Banerjee D., and Shah D. Cholelithiasis in a child-an unusual presentation of Wilson's disease. J. Assoc. Physicians India 49 (2001) 1118-1119
22. Harada Y., Iwai M., Kakusui M., Mori T., Tada K., Ishii Y., Okanoue T., and Kashima K. Activated hepatic stellate cells participate in liver fibrosis in a patient with transfusional iron overload. J. Gastroenterol. 33 (1998) 751-754
23. Harrison's Principles of Internal Medicine 2001. Braunwald, E., Hansen, S.L., Fauci, A.S., Longo, D.L., Kasper, D.L., Jameson, J.L. (eds.), McGraw-Hill, New York.
24. Hertz T., Dullmann J., and Nielsen P. Transport of siderotic Kupffer cells to the lung and bronchial excretion of iron in experimental iron-overload. Acta Anat. 145 (1992) 378-381
25. Inan C., Kiline K., Kotiloglu E., Akman H.O., Kilic I., and Michl J. Antioxidant therapy of cobalt and vitamin E in hemosiderosis. J. Lab. Clin. Med. 132 (1998) 157-165
26. Izaks G.J., Westendorp R.G.J., and Knook D.L. The definition of anemia in older persons. JAMA 281 18 (1999) 1714-1717
27. Khan M.F., Wu X., Tipnis U.R., Ansari G.A.S., and Boor P.J. Protein adducts of malondialdehyde and 4-hydroxynonenal in livers of iron loaded rats: quantitation and localization. Toxicology 173 (2002) 193-201
28. Leonardi P., and Ruol A. Renal hemosiderosis in the hemolytic anemias: diagnosis by means of needle biopsy. Blood 16 (1960) 1029
29. Marchetti M., Quaglini S., and Barosi G. Prophylactic splenectomy and cholecystectomy in mild hereditary spherocytosis: analyzing the decision in different clinical scenarios. J. Intern. Med. 244 3 (1998) 217-226
30. Matsuno T., Mori M., and Awai M. Distribution of ferritin and hemosiderin in the liver, spleen and bone marrow of normal, phlebotomized and iron overloaded rats. Acta Med. Okayama 39 (1985) 347-360
31. Miyazaki E., Kato J., Kobune M., Okumura K., Sasaki K., Shintani N., Arosio P., and Niitsu Y. Denatured H-ferritin subunit is a major constituent of haemosiderin in the liver of patients with iron overload. Gut 50 (2002) 413-419
32. Nyska A., Haseman J.K., Kohen R., and Maronpot R.R. Association of liver hamangiosarcoma and secondary iron overload in B6C3F1 mice-the National Toxicology Program experience. Toxicol. Pathol. 32 (2004) 222-228
33. Parkes J.G., and Templeton D.M. Modulation of stellate cell proliferation and gene expression by rat hepatocytes: effect of toxic iron overload. Toxicol. Lett. 144 (2003) 225-233
34. Penninx B.W., Guralnik J.M., Onder G., Ferrucci L., Wallace R.B., and Pahor M. Anemia and decline in physical performance among older persons. Am. J. Med. 115 2 (2003) 104-110
35. Riede U.-N., Schaefer H.-E., Denk H., and Stolte M. Hepatopankreatisches system. In: Riede U.-N., Schaefer H.-E., and Wehner H. (Eds). Allgemeine und spezielle Pathologie (1989), Georg Thieme Verlag Stuttgart 669-723
36. Rockwood G.A., Armstron K.R., and Baskin S.I. Species comparison of methemoglobin reductase. Exp. Biol. Med. 228 (2003) 79-83
37. Sandler A., Winkel G., Kimura K., and Soper R. The role of prophylactic cholecystectomy during splenectomy in children with hereditary spherocytosis. J. Pediatr. Surg. 34 7 (1999) 1077-1078
38. Schaefer H.-E., Hernst E.W., and Riede U.-N. Hämatopoetisches und lymphatisches system. In: Riede U.-N., Schaefer H.-E., and Wehner H. (Eds). Allgemeine und spezielle Pathologie (1989), Georg Thieme Verlag Stuttgart 471-528
39. SCP (Scientific Committee on Plants), (2002). Opinion on Specific Questions from the Commission Concerning the Evaluation of Indoxacarb in the Context of Council Directive 91/414/eec. .
40. Seifert M.F., and Marks S.C. The regulation of hemopoiesis in the spleen. Experientia 41 (1985) 192-199
41. Selden C., Owen M., Hopkins J.M., and Peters T.J. Studies on the concentration and intracellular localization of iron proteins in liver biopsy specimens from patients with iron overload with special reference to their role in lysosomal disruption. Br. J. Haematol. 44 (1980) 593-603
42. Smith J.E. Iron metabolism and its disorders. In: Kaneko J.J., Harvey J.W., and Bruss M.L. (Eds). Clinical Biochemistry of Domestic Animals (1997), Academic Press, New York 223-239
43. Smith R.P. Toxic Responses of the Blood. Casarett and Doull's Toxicology. third ed. (1986), Macmillan Publishing Company, New York, Toronto, London
44. Sprague W.S., Hackett T.B., Johnson J.S., and Swardson-Olver C.J. Hemochromatosis secondary to repeated blood transfusions in a dog. Vet. Pathol. 40 (2003) 334-337
45. Tapiero H., Gate L., and Tew K.D. Iron: deficiencies and requirements. Biomed. Pharmacother. 55 6 (2001) 324-332
46. Tiniakos G., and Williams R. Cirrhotic process, liver cell carcinoma and extrahepatic malignant tumors in idiopathic haemochromatosis. Appl. Pathol. 6 (1988) 128-138
47. Tunaci M., Tunaci A., Engin G., Ozkorkmaz B., Dincol G., Acunas G., and Acunas B. Imaging features of thalassemia. Eur. Radiol. 9 (1999) 1804-1809
48. Vacha J., Hola J., Dungel J., and Znojil V. The distribution of erythropoiesis over the various anatomical regions of the erythropoietic system in some inbred strains of mice. Exp. Hematol. 10 (1982) 768-773
49. Watanabe K., Yamashita Y., Ohgawara H., Sekiguchi M., Satake N., Orino K., and Yamamoto S. Iron content of rat serum ferritin. J. Vet. Med. Sci. 63 (2001) 587-589
50. Weinberg E.D. Iron in neoplastic disease. Nutr. Cancer. 4 (1983) 223-233
51. World Health Organization. 1968. Nutritional Anaemias: Report of a WHO Scientific Group. Geneva, Switzerland: World Health Organization.
52. Zhou X.J., Laszik Z., Wang X.Q., Silva F.G., and Vaziri N.D. Association of renal injury with increased oxygen free radical activity and altered nitric oxide metabolism in chronic experimental hemosiderosis. Lab. Invest. 80 (2000) 1905-1914
53. Zuyderhoudt F.M., Sindram J.W., Marx J.J., Jorning G.G., and van Gool J. The amount of ferritin and hemosiderin in the livers of patients with iron-loading diseases. Hepatology 3 (1983) 232-235